-
IntroducedFeb 03, 2025
-
Passed House
-
Passed Senate
-
Signed into Law
Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.
Last Action See all actions
House • Feb 11, 2025: Hearing: Tuesday, February 11, 2025, 1:30 PM Room 112-N
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on HB 2218
Tweets
Whip Lists
Sponsors
- Committee on Health and Human Servicessponsor
Votes
Looks like there aren't any voting records available at this moment.
Actions
- Feb 11, 2025 | House
- Hearing: Tuesday, February 11, 2025, 1:30 PM Room 112-N
- Feb 03, 2025 | House
- Introduced
- Referred to Committee on Health and Human Services
Bill Texts
Documents
- As introduced - Supplementary Note
- House Committee on Health and Human Services, Tue, Feb 11, 2025: Minutes
- House Committee on Health and Human Services, Tue, Feb 11, 2025: Testimony by Tess Bettler, Compass Pathways (A01 HB2218)
- House Committee on Health and Human Services, Tue, Feb 11, 2025: Testimony by James Davis, Private Citizen (A02 HB2218)
- House Committee on Health and Human Services, Tue, Feb 11, 2025: Testimony by Alexandra Blasi, Kansas Board of Pharmacy (A03 HB2218)
×
Try FastDemocracy Professional
Try FastDemocracy Professional
Are you part of a non-profit, business, government relations firm or association? We can take your advocacy to the next level!
Report a comment
×
Do you want to add this event to your calendar?